$2.490
-0.020 (-0.80%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de EDIT por análisis de gráficos similares
Alphio's EDIT stock price prediction model matches the current Editas Medicine Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.39 (-0.51%). The 1-week path is $2.43 (+1.45%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Editas Medicine Inc?
Editas Medicine Inc is a good buy right now due to its recent clinical trial approval for EDIT-401, which has shown promising results in reducing bad cholesterol by approximately 90%. The current price is $2.35, significantly below the analyst price target of $6, indicating a potential upside of 114%. Additionally, the stock has a gross margin of 100%, showing strong profitability potential. However, the main risk is the company's high debt-to-equity ratio of 1240.40%, which could impact financial stability if not managed carefully.
EDIT cerró en $2.49 el Thursday, tras bajar -0.80%
Editas Medicine Inc (EDIT) last closed at $2.4, losing -3.61%. These facts feed the 1-day and 1-week EDIT price prediction above.
Consenso de analistas
Editas Medicine Inc (EDIT): 4 comprar, 4 mantener, 0 vender. Perspectiva: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Editas Medicine Inc (EDIT) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de EDIT, ordenadas por similitud.
Análisis de estacionalidad de EDIT
Historically the probability of a positive October return for EDIT is 63.49%. June offers the highest probability of a positive month at 68.33%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de EDIT
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $3.46 | $3.63 | $3.73 | +51.34% |
| Nov 2026 | $2.76 | $2.92 | $3.42 | +21.72% |
| Dec 2026 | $2.59 | $2.96 | $3.62 | +23.40% |
En 2026, se proyecta que Editas Medicine Inc (EDIT) oscile entre $2.59 y $3.73.
Previsión mensual de Editas Medicine Inc para 2026
En Oct de 2026, se proyecta que Editas Medicine Inc promedie $3.63, con un mínimo de $3.46 y un máximo de $3.73.
En Nov de 2026, se proyecta que Editas Medicine Inc promedie $2.92, con un mínimo de $2.76 y un máximo de $3.42.
En Dec de 2026, se proyecta que Editas Medicine Inc promedie $2.96, con un mínimo de $2.59 y un máximo de $3.62.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.